Vivet Therapeutics - innovative gene therapy treatments for orphan diseases
innovative gene therapy treatments for orphan diseases
Toggle menu
About us
Our DNA
Board members
Our leadership
Partners
Pipeline
VTX-801 – Wilson’s disease
> VTX-801 in Wilson disease – GATEWAY – Phase 1/2 Clinical Trial
VTX-802 & VTX-803 – PFIC
VTX-804 – Citrullinemia Type 1
Investors
News
Events
Patients & Families
Patient advocacy
Patient & Families ressources
Compassionate Use and Expanded Access
Work at Vivet
head of board
Vivet Therapeutics
→
head of board
Pfizer Ventures
Rana Al-Hallaq, PhD
Co-founder & CEO
Jean-Philippe Combal, PharmD, PhD
Chairman of the Board
Eduardo Bravo, MBA
